Two cases of relapsed HIV-associated visceral leishmaniasis successfully treated with combination therapy.
Antonio MastroianniPaolo GaibaniGiada RossiniCaterina VocaleMaria Carla ReGianfranco RavagliaVittorio SambriStefania VaraniPublished in: AIDS research and therapy (2018)
Results achieved with the anti-leishmanial combination treatment were promising, but are based on only two patients. Future investigation is necessary to confirm the efficacy of this salvage therapy in sustaining the immunological response and control of VL.
Keyphrases
- combination therapy
- end stage renal disease
- newly diagnosed
- ejection fraction
- acute lymphoblastic leukemia
- hiv positive
- chronic kidney disease
- prognostic factors
- acute myeloid leukemia
- human immunodeficiency virus
- hepatitis c virus
- hiv infected
- diffuse large b cell lymphoma
- peritoneal dialysis
- multiple myeloma
- hiv aids
- stem cells
- hodgkin lymphoma
- mesenchymal stem cells
- bone marrow
- men who have sex with men
- south africa
- replacement therapy